Benjamin B. Mull
Impact in
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
-
- CAR-T cell therapy research
Papers in
- Co-authors
- Manfred Herold (3 shared papers)W. Aulitzky (2 shared papers)Arthur L. Beaudet (3 shared papers)C. Huber (2 shared papers)Günther Gastl (2 shared papers)J. Frick (1 shared paper)Estuardo Aguilar-Córdova (2 shared papers)Khandan Keyomarsi (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Human Gene Therapy (1 paper)British Journal of Cancer (1 paper)Journal of Inherited Metabolic Disease (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesAustriaNetherlands
In The Last Decade
Benjamin B. Mull
12 papers receiving 397 citations
Peers
Comparison fields: 5 of 71
- Clinical Biochemistry 50
- Oncology 132
- Genetics 131
- Immunology 89
- Hematology 37
Countries citing papers authored by Benjamin B. Mull
This map shows the geographic impact of Benjamin B. Mull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin B. Mull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin B. Mull more than expected).
Fields of papers citing papers by Benjamin B. Mull
This network shows the impact of papers produced by Benjamin B. Mull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin B. Mull. The network helps show where Benjamin B. Mull may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin B. Mull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 97 | |
| 2 | 1998 | 90 | |
| 3 | In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). | 1988 | 73 |
| 4 | 1999 | 44 | |
| 5 | 2004 | 27 | |
| 6 | 1998 | 17 | |
| 7 | Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study. | 1994 | 15 |
| 8 | 1988 | 12 | |
| 9 | 2020 | 12 | |
| 10 | 1995 | 12 | |
| 11 | 2009 | 10 | |
| 12 | Tolerance and Effectiveness of Combined Il-3 and G-csf in Collecting Peripheral-blood Progenitor Cells (pbpc) Following Disease-oriented Chemotherapy | 1993 | 1 |
About Benjamin B. Mull
Benjamin B. Mull is a scholar working on Oncology, Genetics, Molecular Biology, Infectious Diseases and Clinical Biochemistry, having authored 12 papers that have together received 410 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (3 papers), Cancer Cells and Metastasis (3 papers), Metabolism and Genetic Disorders (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Neutropenia and Cancer Infections (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Clinical Biochemistry (50 citations), Oncology (132 citations), Genetics (131 citations), Immunology (89 citations) and Hematology (37 citations). Benjamin B. Mull has collaborated with scholars based in United States, Austria and Netherlands. Frequent co-authors include Manfred Herold, W. Aulitzky, Arthur L. Beaudet, C. Huber, Günther Gastl, J. Frick, Estuardo Aguilar-Córdova, Khandan Keyomarsi, Claire Langston and Wanda K. O’Neal. Their work appears in journals such as Journal of Clinical Oncology, Human Gene Therapy, British Journal of Cancer, Journal of Inherited Metabolic Disease and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.